Innospec (IOSP) financial statements
Innospec reported revenue of $1.8B in fiscal 2025, up 8.1% a year over 9 years.
Net income was $117M and the operating margin 7.3%, against 11.1% in 2016.
Free cash flow was $63M, and the company returned $42M in dividends and $24M in net buybacks.
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Innospec's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $883M | $1.3B | $1.5B | $1.5B | $1.2B | $1.5B | $2.0B | $1.9B | $1.8B | $1.8B |
| Cost of revenue | $551M | $904M | $1.0B | $1.0B | $850M | $1.0B | $1.4B | $1.4B | $1.3B | $1.3B |
| Gross profit | $332M | $403M | $435M | $466M | $343M | $435M | $587M | $591M | $543M | $492M |
| Research and development | $25M | $31M | $33M | $35M | $31M | $37M | $39M | $49M | $56M | $51M |
| Selling, general and admin | $217M | $244M | $261M | $281M | $237M | $267M | $361M | $380M | $305M | $285M |
| Operating income | $98M | $125M | $134M | $150M | $34M | $132M | $187M | $162M | $178M | $130M |
| Interest expense | $3M | $7M | $6M | $5M | $800,000 | $0 | $0 | $0 | $0 | $0 |
| Pre-tax income | $103M | $128M | $132M | $150M | $40M | $134M | $185M | $174M | $41M | $138M |
| Income tax | $22M | $66M | $47M | $38M | $11M | $41M | $52M | $35M | $6M | $22M |
| Net income | $81M | $62M | $85M | $112M | $29M | $93M | $133M | $139M | $36M | $117M |
| EPS (diluted) | $3.33 | $2.52 | $3.45 | $4.54 | $1.16 | $3.75 | $5.32 | $5.56 | $1.42 | $4.67 |
| Diluted shares | 24M | 24M | 25M | 25M | 25M | 25M | 25M | 25M | 25M | 25M |
| Gross margin | 37.6% | 30.9% | 29.5% | 30.8% | 28.7% | 29.3% | 29.9% | 30.3% | 29.4% | 27.7% |
| Operating margin | 11.1% | 9.6% | 9.0% | 9.9% | 2.8% | 8.9% | 9.5% | 8.3% | 9.6% | 7.3% |
| Net margin | 9.2% | 4.7% | 5.8% | 7.4% | 2.4% | 6.3% | 6.8% | 7.1% | 1.9% | 6.6% |
Balance sheet
Fiscal years, from Innospec's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $102M | $90M | $123M | $76M | $105M | $142M | $147M | $204M | $289M | $292M |
| Receivables | $154M | $244M | $280M | $292M | $221M | $284M | $335M | $360M | $342M | $342M |
| Inventory | $174M | $210M | $248M | $245M | $220M | $278M | $373M | $300M | $301M | $329M |
| Total current assets | $441M | $562M | $664M | $630M | $566M | $728M | $873M | $886M | $957M | $1.0B |
| Property, plant and equipment | $157M | $196M | $196M | $199M | $211M | $214M | $221M | $268M | $270M | $286M |
| Goodwill | $375M | $362M | $365M | $363M | $371M | $364M | $359M | $399M | $382M | $399M |
| Total assets | $1.2B | $1.4B | $1.5B | $1.5B | $1.4B | $1.6B | $1.6B | $1.7B | $1.7B | $1.8B |
| Total current liabilities | $183M | $262M | $297M | $304M | $252M | $337M | $406M | $372M | $371M | $360M |
| Long-term debt | $258M | $203M | $186M | $59M | $0 | — | — | — | — | — |
| Total liabilities | $528M | $616M | $648M | $550M | $452M | $538M | $563M | $558M | $519M | $500M |
| Shareholders' equity | $654M | $794M | $825M | -$74M | $944M | $1.0B | $1.0B | $1.1B | $1.2B | $1.3B |
| Net debt | $167M | $128M | $84M | -$17M | -$105M | -$142M | -$147M | -$204M | -$289M | -$292M |
Cash flow
Fiscal years, from Innospec's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $106M | $83M | $105M | $162M | $146M | $93M | $82M | $207M | $184M | $138M |
| Capital spending | $16M | $28M | $30M | $31M | $30M | $39M | $42M | $77M | $62M | $76M |
| Free cash flow | $89M | $55M | $75M | $131M | $116M | $54M | $39M | $130M | $122M | $63M |
| Stock-based compensation | $3M | $4M | $5M | $7M | $6M | $4M | $7M | $8M | $8M | $8M |
| Dividends paid | $16M | $19M | $22M | $25M | $26M | $29M | $32M | $35M | $39M | $42M |
| Share buybacks (net) | -$8M | -$1M | -$1M | -$2M | -$2M | -$800,000 | -$6M | -$1M | -$700,000 | -$24M |
| Free cash flow margin | 10.1% | 4.2% | 5.1% | 8.6% | 9.7% | 3.6% | 2.0% | 6.7% | 6.6% | 3.5% |
| Dividends per share | $0.65 | $0.76 | $0.88 | $1.01 | $1.03 | $1.16 | $1.27 | $1.40 | $1.54 | $1.70 |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for IOSP.
Open IOSP in InvestinglyQuestions
What was Innospec's revenue in 2025?
$1.8B in fiscal 2025, from its 10-K filing.
How much free cash flow does Innospec generate?
$63M in fiscal 2025 (operating cash flow minus capital spending).
From Innospec's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.